Found: 11
Select item for more details and to access through your institution.
Effectiveness and Safety of Switching Originator and Biosimilar Epoetins in Patients with Chronic Kidney Disease in a Large-Scale Italian Cohort Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
In Search of Predictors of Switching Between Erythropoiesis-Stimulating Agents in Clinical Practice: A Multi-Regional Cohort Study.
- Published in:
- BioDrugs, 2020, v. 34, n. 1, p. 55, doi. 10.1007/s40259-019-00385-y
- By:
- Publication type:
- Article
How did the Introduction of Biosimilar Filgrastim Influence the Prescribing Pattern of Granulocyte Colony-Stimulating Factors? Results from a Multicentre, Population-Based Study, from Five Italian Centres in the Years 2009-2014.
- Published in:
- BioDrugs, 2016, v. 30, n. 4, p. 295, doi. 10.1007/s40259-016-0175-4
- By:
- Publication type:
- Article
How Much Are Biosimilars Used in Clinical Practice? A Retrospective Italian Population-Based Study of Erythropoiesis-Stimulating Agents in the Years 2009-2013.
- Published in:
- BioDrugs, 2015, v. 29, n. 4, p. 275, doi. 10.1007/s40259-015-0132-7
- By:
- Publication type:
- Article
Oral Agents for Treatment of Patients with Advanced Pancreatic Neuroendocrine Tumors: Could Pharmaeconomic, Cost-Effectiveness Data Play a Significant Role?
- Published in:
- JOP Journal of the Pancreas, 2013, v. 14, n. 1, p. 102
- By:
- Publication type:
- Article
Pattern of Use of Biosimilar and Originator somatropin in italy: a Population-Based Multiple Databases study During the Years 2009-2014.
- Published in:
- Frontiers in Endocrinology, 2018, p. 1, doi. 10.3389/fendo.2018.00095
- By:
- Publication type:
- Article
Real World Use of Antidiabetic Drugs in the Years 2011–2017: A Population-Based Study from Southern Italy.
- Published in:
- International Journal of Environmental Research & Public Health, 2020, v. 17, n. 24, p. 9514, doi. 10.3390/ijerph17249514
- By:
- Publication type:
- Article
Direct healthcare costs of chronic kidney disease management in Italy: What cost‐savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis‐stimulating agents?
- Published in:
- Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 1, p. 65, doi. 10.1002/pds.5152
- By:
- Publication type:
- Article
Analisi dell'epidemiologia e della farmaco-utilizzazione dei pazienti affetti da trombocitopenia immune primaria in contesti italiani.
- Published in:
- Giornale Italiano di Health Technology Assessment Delivery, 2021, v. 14, n. 2, p. 1
- By:
- Publication type:
- Article
Characteristics and Drug Utilization of Patients with Hereditary Angioedema in Italy, a Real-World Analysis.
- Published in:
- Healthcare (2227-9032), 2023, v. 11, n. 18, p. 2509, doi. 10.3390/healthcare11182509
- By:
- Publication type:
- Article
Comparison of Direct Oral Anticoagulant Use for the Treatment of Non-Valvular Atrial Fibrillation in Pivotal Clinical Trials vs. the Real-World Setting: A Population-Based Study from Southern Italy.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 4, p. 290, doi. 10.3390/ph14040290
- By:
- Publication type:
- Article